BRAIN STIMULATION PROGRAMMING
    72.
    发明申请

    公开(公告)号:US20180085590A1

    公开(公告)日:2018-03-29

    申请号:US15830814

    申请日:2017-12-04

    Inventor: Steven M. Goetz

    CPC classification number: A61N1/372 A61N1/00 A61N1/37247

    Abstract: A programming system allows a user to program therapy parameter values for therapy delivered by a medical device by specifying a desired therapeutic outcome. In an example, the programming system presents a model of a brain network associated with a patient condition to the user. The model may be a graphical representation of a network of anatomical structures of the brain associated with the patient condition and may indicate the functional relationship between the anatomical structures. Using the model, the user may define a desired therapeutic outcome associated with the condition, and adjust excitatory and/or inhibitory effects of the stimulation on the anatomical structures. The system may determine therapy parameter values for therapy delivered to the patient based on the user input.

    AUTOMATED PROGRAMMING OF ELECTRICAL STIMULATION ELECTRODES USING POST-IMPLANT IMAGING
    75.
    发明申请
    AUTOMATED PROGRAMMING OF ELECTRICAL STIMULATION ELECTRODES USING POST-IMPLANT IMAGING 审中-公开
    使用后植入图像自动编程电刺激电极

    公开(公告)号:US20140371819A1

    公开(公告)日:2014-12-18

    申请号:US14476309

    申请日:2014-09-03

    Abstract: In general, the disclosure is related to characterization of implanted electrical stimulation electrode arrays using post-implant imaging. The electrode arrays may be carried by implanted leads. Characterization of implanted electrode arrays may include identification of the type or types of leads implanted within a patient and/or determination of positions of the implanted leads or electrodes carried by the leads relative to one another or relative to anatomical structures within the patient. In addition, the disclosure relates to techniques for specifying or modifying patient therapy parameters based on the characterization of the implanted electrode arrays.

    Abstract translation: 通常,本公开涉及使用植入后成像的植入电刺激电极阵列的表征。 电极阵列可以由注入引线携带。 植入电极阵列的表征可以包括识别植入在患者体内的引线的类型或类型,和/或确定由导线相对于彼此或相对于患者内的解剖结构承载的植入引线或电极的位置。 此外,本公开涉及基于植入的电极阵列的表征来指定或修改患者治疗参数的技术。

    PROGRAMMING TECHNIQUES FOR PERIPHERAL NERVE FIELD STIMULATION
    76.
    发明申请
    PROGRAMMING TECHNIQUES FOR PERIPHERAL NERVE FIELD STIMULATION 审中-公开
    外周神经网络刺激的编程技术

    公开(公告)号:US20140371813A1

    公开(公告)日:2014-12-18

    申请号:US14477591

    申请日:2014-09-04

    Abstract: A therapy program for peripheral nerve field stimulation (PNFS) may be selected based on user input indicating a desired therapeutic effect for a user-specified region in which a patient feels pain. In other examples, PNFS may be programmed based on input from a user selecting at least one region from among a plurality of regions in which the patient experiences pain. In addition, the PNFS may be programmed based on user input defining an aspect of PNFS for the selected region, such as a relative intensity of PNFS delivered to at least two selected regions, a balance of PNFS between at least two regions, a desired shift in PNFS from a first region to a second region, or an extent to which a first stimulation field within a first region overlaps with a second stimulation field in a second region.

    Abstract translation: 可以基于用户输入指示用于周围神经区域刺激(PNFS)的治疗程序,其指示患者感觉疼痛的用户指定区域的期望的治疗效果。 在其他示例中,PNFS可以基于来自用户的输入来编程,所述用户从患者经历疼痛的多个区域中选择至少一个区域。 另外,PNFS可以基于定义用于所选区域的PNFS的方面的用户输入来编程,例如递送到至少两个选择的区域的PNFS的相对强度,至少两个区域之间的PNFS的平衡,期望的移位 在PNFS中从第一区域到第二区域,或第一区域内的第一刺激场与第二区域中的第二刺激场重叠的程度。

    REMOTE TITRATION OF THERAPY DELIVERED BY AN IMPLANTABLE MEDICAL DEVICE
    77.
    发明申请
    REMOTE TITRATION OF THERAPY DELIVERED BY AN IMPLANTABLE MEDICAL DEVICE 审中-公开
    远程治疗由可植入医疗器械提供的治疗

    公开(公告)号:US20140107567A1

    公开(公告)日:2014-04-17

    申请号:US14137673

    申请日:2013-12-20

    Inventor: Steven M. Goetz

    Abstract: Techniques for remotely titrating a therapy delivered using an implantable medical device system are disclosed. An implantable medical device delivers therapy according to a first program. The system collects patient data relating to at least one of an efficacy of, or side effects resulting from, the delivered therapy, and transmits the patient data to a remote network device. A clinician may then analyze the patient data and determine if changes to the therapy are warranted. The clinician may then transmit a programming change, e.g., a modification to the first program or a new, second program, to the implantable medical device system, and the implantable medical device may deliver therapy according to the changed programming. The process of receiving patient data and modifying the therapy programming may be repeated multiple times until the therapy is adequately titrated, e.g., until the patient data indicates adequate efficacy and/or acceptable side effects.

    Abstract translation: 公开了用于远程滴定使用可植入医疗装置系统递送的治疗的技术。 可植入医疗装置根据第一程序递送治疗。 系统收集与递送的治疗产生的功效或副作用中的至少一个相关的患者数据,并将患者数据发送到远程网络设备。 然后,临床医师可以分析患者数据并确定是否需要对治疗进行改变。 临床医生然后可以将编程改变例如对第一程序或新的第二程序的修改发送到可植入医疗设备系统,并且可植入医疗设备可以根据改变的程序传递治疗。 接收患者数据和修改治疗程序的过程可以重复多次,直到治疗被充分滴定,例如,直到患者数据表明足够的功效和/或可接受的副作用。

Patent Agency Ranking